<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Examples of agents that can precipitate serotonin syndrome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Examples of agents that can precipitate serotonin syndrome</h1>
<div class="graphic"><div class="figure"><div class="ttl">Examples of agents that can precipitate serotonin syndrome</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup width="70%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Mechanism</td> <td class="subtitle1_left">Agent involved</td> </tr> <tr> <td>Increases serotonin formation</td> <td>Tryptophan, oxitriptan<sup>*</sup></td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="5">Increases release of serotonin</td> <td>Amphetamines (including dextroamphetamine, methamphetamine)</td> </tr> <tr class="highlight_lght_gray_text"> <td>MDMA (ecstasy)</td> </tr> <tr class="highlight_lght_gray_text"> <td>Amphetamine derivatives (including fenfluramine, dexfenfluramine, phentermine)</td> </tr> <tr class="highlight_lght_gray_text"> <td>Cocaine</td> </tr> <tr class="highlight_lght_gray_text"> <td>Mirtazapine</td> </tr> <tr> <td rowspan="17">Impairs serotonin reuptake from the synaptic cleft into the presynaptic neuron</td> <td>Cocaine</td> </tr> <tr> <td>MDMA (ecstasy)</td> </tr> <tr> <td>Meperidine</td> </tr> <tr> <td>Tramadol</td> </tr> <tr> <td>Pentazocine</td> </tr> <tr> <td>Dextromethorphan</td> </tr> <tr> <td>Selective serotonin reuptake inhibitors (SSRIs; citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline)</td> </tr> <tr> <td>Serotonin-norepinephrine reuptake inhibitors (SNRIs; desvenlafaxine, duloxetine, levomilnacipran, milnacipran, and venlafaxine)</td> </tr> <tr> <td>Sibutramine</td> </tr> <tr> <td>Bupropion<sup>¶</sup></td> </tr> <tr> <td>Serotonin modulators (nefazodone, trazodone, vilazodone, and vortioxetine)</td> </tr> <tr> <td>Cyclic antidepressants (amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, maprotiline, nortriptyline, protriptyline, trimipramine)</td> </tr> <tr> <td>St. John's wort (<em>Hypericum perforatum</em>)</td> </tr> <tr> <td>5-HT3 receptor antagonists (dolasetron, granisetron, ondansetron, palonosetron)</td> </tr> <tr> <td>Cyclobenzaprine</td> </tr> <tr> <td>Methylphenidate, dexmethylphenidate</td> </tr> <tr> <td>Lamotrigine</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="3">Inhibits serotonin metabolism by inhibition of MAO</td> <td>MAO inhibitors, nonselective (isocarboxazid, linezolid, phenelzine, Syrian rue [<em>Peganum harmala</em>, harmine], and tranylcypromine)</td> </tr> <tr class="highlight_lght_gray_text"> <td>MAO-A inhibitors<sup>Δ</sup> (methylene blue, moclobemide)</td> </tr> <tr class="highlight_lght_gray_text"> <td>MAO-B inhibitors<sup>Δ</sup> (rasagiline, safinamide, and selegiline)</td> </tr> <tr> <td rowspan="8">Direct serotonin receptor agonist</td> <td>Buspirone</td> </tr> <tr> <td>Triptans (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan)</td> </tr> <tr> <td>Ergot derivatives (including dihydroergotamine, ergotamine, methylergonovine)</td> </tr> <tr> <td>Fentanyl</td> </tr> <tr> <td>Lysergic acid diethylamide (LSD)</td> </tr> <tr> <td>Lasmiditan</td> </tr> <tr> <td>Lorcaserin<sup>◊</sup></td> </tr> <tr> <td>Metaxalone</td> </tr> <tr class="highlight_lght_gray_text"> <td>Increases sensitivity of postsynaptic serotonin receptor</td> <td>Lithium</td> </tr> </tbody></table></div><div class="graphic_lgnd">Serotonin syndrome is a potentially life-threatening condition associated with increased serotonergic activity in the CNS. Serotonin syndrome can occur with therapeutic medication use, overdose, or as the result of additive or synergistic effects due to drug interaction(s). For additional information on clinical use and precautions related to serotonergic effects, refer to UpToDate topic reviews including the serotonin syndrome topic and Lexicomp drug monographs and <a href="https://www.uptodate.com/drug-interactions">Lexicomp drug interactions</a> program included within UpToDate.</div><div class="graphic_footnotes"><p>CNS: central nervous system; MAO: monoamine oxidase; OTC: over-the-counter.</p>
<p>* Within the United States, tryptophan (L-tryptophan) and oxitriptan are available as OTC supplements. In other areas, these agents may be available OTC or by prescription.</p>
<p>¶ Bupropion inhibits neuronal uptake of dopamine and norepinephrine without known effects on serotonin; however, there have been case reports of serotonin syndrome when co-administered with other serotonergic drugs (eg, SSRIs); in some cases this may have been due to bupropion's inhibition of SSRI metabolism by CYP2D6.</p>
<p>Δ MAO selectivity is lost at higher doses and with drug interactions that increase serum drug concentrations. Inhibition of MAO-A is more likely to result in increased levels of serotonin within the CNS (ie, increased risk of serotonin syndrome) relative to MAO-B inhibition.</p>
◊ Withdrawn from United States market.</div><div class="graphic_reference">Data from:
<ol>
<li>Boyer EW, Shannon M. The serotonin syndrome. NEJM 2005; 352:1112.</li>
<li>Finberg JPM, Rabey JM. Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 2016; 7:340.</li>
<li>Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</li>
</ol></div><div id="graphicVersion">Graphic 64604 Version 24.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
